Inhibiting the inflammasome with MCC950 counteracts muscle pyroptosis and improves Duchenne muscular dystrophy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibiting the inflammasome with MCC950 counteracts muscle pyroptosis and improves Duchenne muscular dystrophy
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-12-07
DOI
10.3389/fimmu.2022.1049076
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Duchenne muscular dystrophy
- (2021) Dongsheng Duan et al. Nature Reviews Disease Primers
- Walking down Skeletal Muscle Lane: From Inflammasome to Disease
- (2021) Nicolas Dubuisson et al. Cells
- AdipoRon , a new therapeutic prospect for Duchenne muscular dystrophy
- (2020) Michel Abou‐Samra et al. Journal of Cachexia Sarcopenia and Muscle
- N-GSDMD trafficking to neutrophil organelles facilitates IL-1β release independently of plasma membrane pores and pyroptosis
- (2020) Mausita Karmakar et al. Nature Communications
- Mechanisms Regulating Muscle Regeneration: Insights into the Interrelated and Time-Dependent Phases of Tissue Healing
- (2020) Laura Forcina et al. Cells
- Mouse CD163 deficiency strongly enhances experimental collagen-induced arthritis
- (2020) Pia Svendsen et al. Scientific Reports
- Genetic disruption of the inflammasome adaptor ASC has minimal impact on the pathogenesis of Duchenne muscular dystrophy in mdx mice
- (2020) Yeh Siang Lau et al. LIFE SCIENCES
- Ponceau S waste: Ponceau S staining for total protein normalization
- (2019) Hannah Sander et al. ANALYTICAL BIOCHEMISTRY
- The selective NLRP3 inflammasome inhibitor MCC950 alleviates cholestatic liver injury and fibrosis in mice
- (2019) Junwen Qu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Duchenne muscular dystrophy awaits gene therapy
- (2019) Dan Jones NATURE BIOTECHNOLOGY
- MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition
- (2019) Rebecca C. Coll et al. Nature Chemical Biology
- MCC950 closes the active conformation of NLRP3 to an inactive state
- (2019) Ana Tapia-Abellán et al. Nature Chemical Biology
- NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia
- (2019) Rebecca Ward et al. PHARMACOLOGICAL RESEARCH
- Downregulation of the NLRP3 inflammasome by adiponectin rescues Duchenne muscular dystrophy
- (2018) Raphaël Boursereau et al. BMC BIOLOGY
- Caspase-1 self-cleavage is an intrinsic mechanism to terminate inflammasome activity
- (2018) Dave Boucher et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Targeting the NLRP3 inflammasome in inflammatory diseases
- (2018) Matthew S. J. Mangan et al. NATURE REVIEWS DRUG DISCOVERY
- MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice
- (2018) Agampodi Promoda Perera et al. Scientific Reports
- Necroptosis mediates myofibre death in dystrophin-deficient mice
- (2018) Jennifer E. Morgan et al. Nature Communications
- MuscleJ: a high-content analysis method to study skeletal muscle with a new Fiji tool
- (2018) Alicia Mayeuf-Louchart et al. Skeletal Muscle
- Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders
- (2017) Hua Jiang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death
- (2017) Jianjin Shi et al. TRENDS IN BIOCHEMICAL SCIENCES
- Recent developments in Duchenne muscular dystrophy: facts and numbers
- (2017) Maggie C. Walter et al. Journal of Cachexia Sarcopenia and Muscle
- Activation of the NLRP3 Inflammasome Is Associated with Valosin-Containing Protein Myopathy
- (2016) Angèle Nalbandian et al. INFLAMMATION
- An NLRP3-specific inflammasome inhibitor attenuates crystal-induced kidney fibrosis in mice
- (2016) Isis Ludwig-Portugall et al. KIDNEY INTERNATIONAL
- Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy
- (2015) J. W. McGreevy et al. Disease Models & Mechanisms
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Developmental myosins: expression patterns and functional significance
- (2015) Stefano Schiaffino et al. Skeletal Muscle
- Involvement of adiponectin in the pathogenesis of dystrophinopathy
- (2015) Michel Abou-Samra et al. Skeletal Muscle
- Utrophin A is essential in mediating the functional adaptations of mdx mouse muscle following chronic AMPK activation
- (2014) H. Al-Rewashdy et al. HUMAN MOLECULAR GENETICS
- Resveratrol decreases inflammation and increases utrophin gene expression in the mdx mouse model of duchenne muscular dystrophy
- (2012) Bradley S. Gordon et al. CLINICAL NUTRITION
- Glucocorticoid Analogues: Potential Therapeutic Alternatives for Treating Inflammatory Muscle Diseases
- (2012) Erica K.M. Reeves et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- The role of branched fibres in the pathogenesis of Duchenne muscular dystrophy
- (2011) S. Chan et al. EXPERIMENTAL PHYSIOLOGY
- Inflammasome Up-Regulation and Activation in Dysferlin-Deficient Skeletal Muscle
- (2010) Rashmi Rawat et al. AMERICAN JOURNAL OF PATHOLOGY
- Branched fibres in old dystrophicmdxmuscle are associated with mechanical weakening of the sarcolemma, abnormal Ca2+transients and a breakdown of Ca2+homeostasis during fatigue
- (2010) Stewart I. Head EXPERIMENTAL PHYSIOLOGY
- Cutting Edge: NF- B Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
- (2009) F. G. Bauernfeind et al. JOURNAL OF IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started